John Oyler, Chief Executive Officer at BeiGene, Ltd. (BGNE), sold 70,820 shares at $245.19 ($17.2M) on 2025-03-10, disclosed to the SEC on 2025-03-12.
Seasonal sale ($17.2M) by Chief Executive Officer — this insider has traded BGNE in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $238.74 | 1,900 | $454K | 2.6% |
| 2 | $239.59 | 6,800 | $1.6M | 9.5% |
| 3 | $240.70 | 2,200 | $530K | 3.1% |
| 4 | $241.92 | 7,069 | $1.7M | 9.9% |
| 5 | $241.92 | 7,069 | $1.7M | 9.9% |
| 6 | $243.04 | 9,309 |
| $2.3M |
| 13.1% |
| 7 | $243.04 | 9,309 | $2.3M | 13.1% |
| 8 | $244.04 | 5,313 | $1.3M | 7.5% |
| 9 | $244.04 | 5,313 | $1.3M | 7.5% |
| 10 | $245.19 | 3,006 | $737K | 4.3% |
| 11 | $245.19 | 3,006 | $737K | 4.3% |
| 12 | $246.11 | 4,913 | $1.2M | 7.0% |
| 13 | $246.11 | 4,913 | $1.2M | 7.0% |
| 14 | $246.85 | 700 | $173K | 1.0% |
| Total | $243.09 avg | 70,820 | $17.2M | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |